Related Experiment Video
Updated: Mar 13, 2026

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
Published on: June 4, 2020
Thromboelastometry guided fibrinogen replacement therapy in cardiac surgery: a retrospective observational study
Francesco Vasques1, Luca Spiezia2, Alberto Manfrini3
1Anesthesiology and Intensive Care Unit, Department of Medicine, Institute of Anesthesia and Intensive Care, University of Padua, Via Cesare Battisti 267, 35121, Padua, Italy. francesco.vasques@hotmail.it.
Point-of-care rotational thromboelastometry (ROTEM) guided bleeding management significantly reduced postoperative blood loss, transfusion needs, and intensive care unit (ICU) stay in cardiac surgery patients compared to conventional methods.
Area of Science:
- Cardiovascular Surgery
- Anesthesiology
- Critical Care Medicine
Background:
- Managing bleeding after cardiac surgery is complex.
- Conventional methods may not always optimize hemostasis.
- Point-of-care testing offers potential for improved patient outcomes.
Purpose of the Study:
- To compare ROTEM-guided hemostasis with conventional management in cardiac surgery.
- To evaluate the impact on postoperative blood loss.
- To assess transfusion requirements and ICU length of stay.
Main Methods:
- Retrospective, observational study.
- Compared 40 patients managed with ROTEM to 40 control patients.
- ROTEM guided hemostatic management versus conventional bleeding management.
Main Results:
- ROTEM group received more fibrinogen (45% vs 10%) but fewer transfusions (40% vs 72.5%).
- Reduced postoperative bleeding (285 mL vs 393 mL) in the ROTEM group.
- Shorter ICU stay (43.7 h vs 52.5 h) for ROTEM-guided patients.
Conclusions:
- ROTEM-guided bleeding management is superior to conventional methods in complex cardiac surgery.
- It leads to decreased postoperative blood loss and transfusion needs.
- It also results in a shorter intensive care unit stay.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Clot Retraction and Fibrinolysis
Anticoagulant Drugs: Low-Molecular-Weight Heparins

